Pyrazole derivative as SCD1 inhibitors for the treatment of diabetes
US8314138B2 · kind B2 · utility
9Cited by
3References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 2007 |
| Grant date | Nov 20, 2012 |
| Priority date | — |
| Expiry date | Nov 12, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides heterocyclic derivatives of formula I that modulate the activity of stearoyl-CoA desaturase. Methods of using such derivatives to modulate the activity of stearoyl-CoA desaturase and pharmaceutical compositions comprising such derivatives are also encompassed.wherein Q is
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.